NDC 63323-134
Pemetrexed
Pemetrexed Disodium
Pemetrexed is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Fresenius Kabi Usa, Llc. The primary component is Pemetrexed Disodium.
| Product ID | 63323-134_6e194cca-07f7-46fb-901b-7b4c606c4d42 |
| NDC | 63323-134 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Pemetrexed |
| Generic Name | Pemetrexed Disodium |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2022-05-25 |
| Marketing Category | ANDA / |
| Application Number | ANDA090384 |
| Labeler Name | Fresenius Kabi USA, LLC |
| Substance Name | PEMETREXED DISODIUM |
| Active Ingredient Strength | 100 mg/4mL |
| Pharm Classes | Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |